Covid 19 en pacientes con enfermedad pulmonar obstructiva crónica (EPOC).

Abstract

Introduction: Since the outbreak in China of SARSCOV-2, which gave rise to what is now known as the COVID-19 pandemic, which today continues to add multiple variants which tend to be more virulent than the past, that is why diseases such as Chronic obstructive pulmonary disease that is considered one of the most common chronic diseases worldwide is the cause of severe COVID-19 symptoms due to exacerbation of symptoms and worsening of the target organ such as the lung and its respiratory annexes, causing a degree of morbidity and mortality higher than in COVID patients who do not have COPD. Objective: This article attempts to summarize, analyze, and describe the complications, symptoms, morbidity, and mortality of COVID-19 in patients with COPD, through a bibliographic review of high-impact scientific literature. 4 Materials and methods: For the realization of this article, several high-impact data sources were taken into account, such as PubMed, Cochrane, Medline, IntraMed, SciELO, WHO, etc., the time range considered was from the year 2020, in English, Spanish and French.Results: 28 scientific articles published in the journals PubMed, EMBASE, Scopus published between April and October 2020 were reviewed. Conclusion: The SARSCoV-2 virus directly affects people who have underlying diseases such as chronic obstructive pulmonary disease, which, being one of the most common in terms of chronic diseases, and patients with COPD have ACE-2 expression in the bronchial epithelial cells in the lower part of the respiratory tract, which is used by SARSCoV-2 to infect the host, therefore these types of patients tend to have more complications than patients who do not have chronic obstructive pulmonary disease.